Advertisement

 

 

[Advance in Diagnose and Treatment Strategies of Adenocarcinoma in Situ].

[Advance in Diagnose and Treatment Strategies of Adenocarcinoma in Situ].
Author Information (click to view)

Qiu Y, Shen-Tu Y,


Qiu Y, Shen-Tu Y, (click to view)

Qiu Y, Shen-Tu Y,

Advertisement

Zhongguo fei ai za zhi = Chinese journal of lung cancer 20(9) 641-644 doi 10.3779/j.issn.1009-3419.2017.09.09
Abstract

Adenocarcinoma in situ (AIS) is a new concept which was introduced to the 2011 The International Association for the Study of Cancer (IASLC)/ American Thoracic Society (ATS)/ European Respiratory Society (ERS) International Multidisciplinary Classification of Lung Adenocarcinoma firstly and an important supplement of The 2015 World Health Organization Classification of Lung Tumors. Because AIS is at an early stage of development of lung adenocarcinoma, the deepening understanding of its pathology, differential diagnosis, treatment strategies, has an important significance for the improvement of the prognosis of lung adenocarcinoma. This review will provide a systematic review of the main progress of occurrence and development, pathological characteristics, differential diagnosis and treatment strategy of AIS, in order to provide theoretical basis for the further research of AIS.

Submit a Comment

Your email address will not be published. Required fields are marked *

15 − 8 =

[ HIDE/SHOW ]